Search research articles
Contact Us
Filters
Showing results (101-110 of 134) with videos related to
Page
of 14
Sort By:
Journal of Crohn'S & Colitis
|
August 12, 2025
Results of the 9th Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): Artificial Intelligence in IBD: Regulatory and Methodological Considerations
Nurulamin M Noor, Marco Daperno, Jan de Laffolie, et al.
Journal of Crohn'S & Colitis
|
August 12, 2025
Results of the Ninth Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): Artificial intelligence in IBD surgery: opportunities and limitations
Alaa El-Hussuna, Gianluca Pellino, Alessandra Soriano, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 16, 2009
Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection
Shomron Ben-Horin, Maya Margalit, Peter Bossuyt, et al.
Journal of Crohn'S & Colitis
|
August 12, 2025
Results of the 9th Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): Artificial Intelligence in medical management and precision medicine
Uri Kopylov, Bram Verstockt, Urko M Marigorta, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 24, 2022
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease
Laurent Peyrin-Biroulet, Jean-François Rahier, Julien Kirchgesner, et al.
Journal of Crohn'S & Colitis
|
August 12, 2025
Results of the 9th Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): Artificial Intelligence in Endoscopy, Radiology and Histology in IBD Diagnostics
Aart Mookhoek, Pieter Sinonque, Mariangela Allocca, et al.
Journal of Crohn'S & Colitis
|
December 3, 2010
Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection
Shomron Ben-Horin, Maya Margalit, Peter Bossuyt, et al.
The Lancet. Gastroenterology & Hepatology
|
January 14, 2023
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial
Edouard Louis, Matthieu Resche-Rigon, David Laharie, et al.
Inflammatory Bowel Diseases
|
November 18, 2021
Recommendations for Standardizing Clinical Trial Design and Endoscopic Assessment in Postoperative Crohn's Disease
Jurij Hanzel, Vipul Jairath, Peter De Cruz, et al.
Gastroenterology
|
January 11, 2018
Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease
Geert D'Haens, Severine Vermeire, Guy Lambrecht, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 134) with videos related to
Sort By:
Page
of 14
Journal of Crohn'S & Colitis
|
August 12, 2025
Results of the 9th Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): Artificial Intelligence in IBD: Regulatory and Methodological Considerations
Nurulamin M Noor, Marco Daperno, Jan de Laffolie, et al.
Journal of Crohn'S & Colitis
|
August 12, 2025
Results of the Ninth Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): Artificial intelligence in IBD surgery: opportunities and limitations
Alaa El-Hussuna, Gianluca Pellino, Alessandra Soriano, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 16, 2009
Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection
Shomron Ben-Horin, Maya Margalit, Peter Bossuyt, et al.
Journal of Crohn'S & Colitis
|
August 12, 2025
Results of the 9th Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): Artificial Intelligence in medical management and precision medicine
Uri Kopylov, Bram Verstockt, Urko M Marigorta, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 24, 2022
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease
Laurent Peyrin-Biroulet, Jean-François Rahier, Julien Kirchgesner, et al.
Journal of Crohn'S & Colitis
|
August 12, 2025
Results of the 9th Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): Artificial Intelligence in Endoscopy, Radiology and Histology in IBD Diagnostics
Aart Mookhoek, Pieter Sinonque, Mariangela Allocca, et al.
Journal of Crohn'S & Colitis
|
December 3, 2010
Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection
Shomron Ben-Horin, Maya Margalit, Peter Bossuyt, et al.
The Lancet. Gastroenterology & Hepatology
|
January 14, 2023
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial
Edouard Louis, Matthieu Resche-Rigon, David Laharie, et al.
Inflammatory Bowel Diseases
|
November 18, 2021
Recommendations for Standardizing Clinical Trial Design and Endoscopic Assessment in Postoperative Crohn's Disease
Jurij Hanzel, Vipul Jairath, Peter De Cruz, et al.
Gastroenterology
|
January 11, 2018
Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease
Geert D'Haens, Severine Vermeire, Guy Lambrecht, et al.
Page
of 14